Inner Mongolia Furui Medical Science Co., Ltd. (SHE: 300049)

Market Cap	9.96B
Revenue (ttm)	1.33B
Net Income (ttm)	130.40M
Shares Out	266.03M
EPS (ttm)	0.49
PE Ratio	76.14
Forward PE	51.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,603,261
Open	39.13
Previous Close	38.20
Day's Range	37.38 - 39.13
52-Week Range	28.73 - 57.50
Beta	-0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Inner Mongolia Furui Medical Science

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. It operates in two segments, pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instruments. It pro...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 703
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300049

Financial Performance

In 2023, Inner Mongolia Furui Medical Science's revenue was 1.15 billion, an increase of 14.37% compared to the previous year's 1.01 billion. Earnings were 101.56 million, an increase of 3.75%.